首页 > 最新文献

International Journal of Pediatric Endocrinology最新文献

英文 中文
Parent-reported outcomes in young children with disorders/differences of sex development. 有性别发育障碍/差异的幼儿的父母报告结果。
Pub Date : 2020-01-01 Epub Date: 2020-02-14 DOI: 10.1186/s13633-020-0073-x
Salma R Ali, Zoe Macqueen, Melissa Gardner, Yiqiao Xin, Andreas Kyriakou, Avril Mason, M Guftar Shaikh, Sze C Wong, David E Sandberg, S Faisal Ahmed

Background: There is a paucity of tools that can be used in routine clinical practice to assess the psychosocial impact of Disorders/Differences of Sex Development (DSD) on parents and children.

Objective: To evaluate the use of short Parent Self-Report and Parent Proxy-Report questionnaires that can be used in the outpatient setting.

Methods: Previously validated DSD-specific and generic items were combined to develop a Parent Self-Report questionnaire and a Parent Proxy-Report questionnaire for children under 7 years. Of 111 children approached at one tertiary paediatric hospital, the parents of 95 children (86%) with DSD or other Endocrine conditions completed these questionnaires.

Results: Questionnaires took under 10 min to complete and were found to be easy to understand. Compared to reference, fathers of children with DSD reported less stress associated with Clinic Visits (p = 0.02) and managing their child's Medication (p = 0.04). However, parents of children with either DSD or other Endocrine conditions reported more symptoms of Depression (p = 0.03). Mothers of children with DSD reported greater Future Concerns in relation to their child's condition (median SDS - 0.28; range - 2.14, 1.73) than mothers of children with other Endocrine conditions (SDS 1.17; - 2.00, 1.73) (p = 0.02). Similarly, fathers of children with DSD expressed greater Future Concerns (median SDS -1.60; - 4.21, 1.00) than fathers of children with other Endocrine conditions (SDS 0.48; - 2.13, 1.52) (p = 0.04).

Conclusion: DSD was associated with greater parental concerns over the child's future than other Endocrine conditions. Brief parent-report tools in DSD can be routinely used in the outpatient setting to assess and monitor parent and patient needs.

背景:在常规临床实践中,缺乏可用于评估性发育障碍/性发育差异(DSD)对父母和儿童的社会心理影响的工具。目的:评价门诊使用家长自述问卷和家长代理报告问卷的可行性。方法:将先前验证过的dsd特异性问卷和通用问卷相结合,编制7岁以下儿童家长自我报告问卷和家长代理报告问卷。在一家三级儿科医院接触的111名儿童中,95名患有DSD或其他内分泌疾病的儿童(86%)的父母完成了这些问卷。结果:问卷在10分钟内完成,并且易于理解。与参考文献相比,患有DSD儿童的父亲报告的与门诊就诊(p = 0.02)和管理孩子的药物(p = 0.04)相关的压力更小。然而,患有DSD或其他内分泌疾病的儿童的父母报告了更多的抑郁症状(p = 0.03)。患有DSD儿童的母亲报告了与孩子状况相关的更大的未来担忧(中位数SDS - 0.28;范围- 2.14,1.73)比患有其他内分泌疾病儿童的母亲(SDS 1.17;- 2.00, 1.73) (p = 0.02)。同样,患有DSD的孩子的父亲表达了更大的未来担忧(中位数SDS -1.60;- 4.21, 1.00)比其他内分泌疾病患儿的父亲(SDS 0.48;- 2.13, 1.52) (p = 0.04)。结论:与其他内分泌疾病相比,DSD与父母对孩子未来的担忧相关。DSD中简短的家长报告工具可常规用于门诊环境,以评估和监测家长和患者的需求。
{"title":"Parent-reported outcomes in young children with disorders/differences of sex development.","authors":"Salma R Ali,&nbsp;Zoe Macqueen,&nbsp;Melissa Gardner,&nbsp;Yiqiao Xin,&nbsp;Andreas Kyriakou,&nbsp;Avril Mason,&nbsp;M Guftar Shaikh,&nbsp;Sze C Wong,&nbsp;David E Sandberg,&nbsp;S Faisal Ahmed","doi":"10.1186/s13633-020-0073-x","DOIUrl":"https://doi.org/10.1186/s13633-020-0073-x","url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of tools that can be used in routine clinical practice to assess the psychosocial impact of Disorders/Differences of Sex Development (DSD) on parents and children.</p><p><strong>Objective: </strong>To evaluate the use of short Parent Self-Report and Parent Proxy-Report questionnaires that can be used in the outpatient setting.</p><p><strong>Methods: </strong>Previously validated DSD-specific and generic items were combined to develop a Parent Self-Report questionnaire and a Parent Proxy-Report questionnaire for children under 7 years. Of 111 children approached at one tertiary paediatric hospital, the parents of 95 children (86%) with DSD or other Endocrine conditions completed these questionnaires.</p><p><strong>Results: </strong>Questionnaires took under 10 min to complete and were found to be easy to understand. Compared to reference, fathers of children with DSD reported less stress associated with Clinic Visits (<i>p</i> = 0.02) and managing their child's Medication (<i>p</i> = 0.04). However, parents of children with either DSD or other Endocrine conditions reported more symptoms of Depression (<i>p</i> = 0.03). Mothers of children with DSD reported greater Future Concerns in relation to their child's condition (median SDS - 0.28; range - 2.14, 1.73) than mothers of children with other Endocrine conditions (SDS 1.17; - 2.00, 1.73) (<i>p</i> = 0.02). Similarly, fathers of children with DSD expressed greater Future Concerns (median SDS -1.60; - 4.21, 1.00) than fathers of children with other Endocrine conditions (SDS 0.48; - 2.13, 1.52) (<i>p</i> = 0.04).</p><p><strong>Conclusion: </strong>DSD was associated with greater parental concerns over the child's future than other Endocrine conditions. Brief parent-report tools in DSD can be routinely used in the outpatient setting to assess and monitor parent and patient needs.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-020-0073-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37664294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The medical transition of young adults with type 1 diabetes (T1D): a retrospective chart review identifies areas in need of improvement. 1 型糖尿病 (T1D) 青壮年患者的医疗过渡:回顾性病历审查确定了需要改进的领域。
Pub Date : 2020-01-01 Epub Date: 2020-05-28 DOI: 10.1186/s13633-020-00080-8
Abby M Walch, Carmen E Cobb, Shirng-Wern Tsaih, Susanne M Cabrera

Background: The transition process from pediatric to adult care in individuals with T1D has long-term ramifications on health outcomes. Recognition of differences in care delivery and changes made in management during this time may improve the process. We hypothesized that pediatric providers would be less likely to address T1D-related comorbidities than their adult counterparts, highlighting opportunities to strengthen care.

Methods: A retrospective chart review of patients aged 16-21 years diagnosed with T1D before age 18 was performed. Data on diagnosis, screening, and management of hypertension, dyslipidemia, microalbuminuria, retinopathy, and neuropathy were collected for 1 year before and 1 year after transition to adult care. The 'ADA Standards of Medical Care in Diabetes' were used to determine adherence to the above parameters. Data before and after transition was compared by Fischer's Exact and Exact McNemar tests.

Results: Complete medical records for 54 subjects were reviewed before and after transition from pediatric to adult care providers within a single academic medical system (52% male; 78% Caucasian). Transition to adult care occurred at a mean age of 18 years. Mean length of transition was 7.8 months with no significant change in an individual's HbA1c over that time. Over the transition period, there was no difference in diagnoses of hypertension or the use of anti-hypertensive. Adherence to lipid and retinopathy screening was similar across the transition period; however, adherence to microalbuminuria screening was higher after the transition to adult providers (p = 0.01). Neuropathy screening adherence was overall poor but also improved after transition (p < 0.001).

Conclusions: Overall, there were no significant changes in the diagnosis or management of several T1D-related comorbidities during the transition period in a small cohort of young adults with T1D. The transition length was longer than the recommended 3-months, highlighting an opportunity to improve the process. There was no deterioration of glycemic control over this time, although HbA1c values were above target. Adult providers had significantly higher rates of adherence to screening for microalbuminuria and neuropathy than their pediatric counterparts, but adherence for neuropathy was quite poor overall, indicating a need for practice improvement.

背景:T1D 患者从儿科护理到成人护理的过渡过程会对健康结果产生长期影响。在这一过程中,认识到护理服务的差异以及在管理方面做出的改变可能会改善这一过程。我们假设,儿科医疗服务提供者比成人医疗服务提供者更少处理与 T1D 相关的合并症,这就凸显了加强护理的机会:方法:我们对 18 岁前被诊断为 T1D 的 16-21 岁患者进行了回顾性病历审查。收集了转为成人护理前一年和转为成人护理后一年的高血压、血脂异常、微量白蛋白尿、视网膜病变和神经病变的诊断、筛查和管理数据。采用 "美国糖尿病协会糖尿病医疗护理标准 "来确定上述参数的遵守情况。过渡前后的数据通过费舍尔精确检验和麦克尼玛精确检验进行比较:在一个学术医疗系统中,对 54 名受试者(52% 为男性;78% 为白种人)从儿科医疗服务提供者转为成人医疗服务提供者前后的完整病历进行了审查。平均年龄为 18 岁。平均过渡时间为 7.8 个月,在此期间个人的 HbA1c 没有明显变化。在过渡期间,高血压诊断或抗高血压药物的使用情况没有差异。在整个过渡期内,血脂和视网膜病变筛查的依从性相似;但在过渡到成人医疗服务提供者后,微量白蛋白尿筛查的依从性更高(p = 0.01)。神经病变筛查的依从性总体较差,但在过渡后也有所改善(p 结论):总体而言,在一小群年轻的 T1D 患者中,过渡期间与 T1D 相关的几种并发症的诊断或管理没有发生重大变化。过渡期长于建议的 3 个月,这表明有机会改进这一过程。虽然 HbA1c 值高于目标值,但在此期间血糖控制没有恶化。成人医疗服务提供者对微量白蛋白尿和神经病变筛查的依从性明显高于儿科医疗服务提供者,但对神经病变筛查的依从性总体较差,这表明需要改进实践。
{"title":"The medical transition of young adults with type 1 diabetes (T1D): a retrospective chart review identifies areas in need of improvement.","authors":"Abby M Walch, Carmen E Cobb, Shirng-Wern Tsaih, Susanne M Cabrera","doi":"10.1186/s13633-020-00080-8","DOIUrl":"10.1186/s13633-020-00080-8","url":null,"abstract":"<p><strong>Background: </strong>The transition process from pediatric to adult care in individuals with T1D has long-term ramifications on health outcomes. Recognition of differences in care delivery and changes made in management during this time may improve the process. We hypothesized that pediatric providers would be less likely to address T1D-related comorbidities than their adult counterparts, highlighting opportunities to strengthen care.</p><p><strong>Methods: </strong>A retrospective chart review of patients aged 16-21 years diagnosed with T1D before age 18 was performed. Data on diagnosis, screening, and management of hypertension, dyslipidemia, microalbuminuria, retinopathy, and neuropathy were collected for 1 year before and 1 year after transition to adult care. The 'ADA Standards of Medical Care in Diabetes' were used to determine adherence to the above parameters. Data before and after transition was compared by Fischer's Exact and Exact McNemar tests.</p><p><strong>Results: </strong>Complete medical records for 54 subjects were reviewed before and after transition from pediatric to adult care providers within a single academic medical system (52% male; 78% Caucasian). Transition to adult care occurred at a mean age of 18 years. Mean length of transition was 7.8 months with no significant change in an individual's HbA1c over that time. Over the transition period, there was no difference in diagnoses of hypertension or the use of anti-hypertensive. Adherence to lipid and retinopathy screening was similar across the transition period; however, adherence to microalbuminuria screening was higher after the transition to adult providers (<i>p</i> = 0.01). Neuropathy screening adherence was overall poor but also improved after transition (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Overall, there were no significant changes in the diagnosis or management of several T1D-related comorbidities during the transition period in a small cohort of young adults with T1D. The transition length was longer than the recommended 3-months, highlighting an opportunity to improve the process. There was no deterioration of glycemic control over this time, although HbA1c values were above target. Adult providers had significantly higher rates of adherence to screening for microalbuminuria and neuropathy than their pediatric counterparts, but adherence for neuropathy was quite poor overall, indicating a need for practice improvement.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38027794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenocortical adenoma in a Sudanese girl with Beckwith-Wiedemann syndrome 苏丹女童贝克威氏综合征的肾上腺皮质腺瘤
Pub Date : 2019-11-22 DOI: 10.1186/s13633-019-0068-7
Eman Abdalla Ali Elnaw, A. Abdalla, M. Abdullah
{"title":"Adrenocortical adenoma in a Sudanese girl with Beckwith-Wiedemann syndrome","authors":"Eman Abdalla Ali Elnaw, A. Abdalla, M. Abdullah","doi":"10.1186/s13633-019-0068-7","DOIUrl":"https://doi.org/10.1186/s13633-019-0068-7","url":null,"abstract":"","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86747406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical and laboratory characteristics and follow up of 62 cases of ketotic hypoglycemia: a retrospective study 62例酮症性低血糖的临床、实验室特点及随访回顾性分析
Pub Date : 2019-11-02 DOI: 10.1186/s13633-019-0066-9
P. Kaplowitz, Hilal Sekizkardes
{"title":"Clinical and laboratory characteristics and follow up of 62 cases of ketotic hypoglycemia: a retrospective study","authors":"P. Kaplowitz, Hilal Sekizkardes","doi":"10.1186/s13633-019-0066-9","DOIUrl":"https://doi.org/10.1186/s13633-019-0066-9","url":null,"abstract":"","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86630806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Precocious puberty and Chiari I malformation with syrinx: a case report of an unusual presentation of Costello syndrome 性早熟和伴鼻咽的Chiari I畸形:一个不寻常的科斯特洛综合征的病例报告
Pub Date : 2019-10-22 DOI: 10.1186/s13633-019-0067-8
Naomi S. Schwartz, Molly O. Regelmann
{"title":"Precocious puberty and Chiari I malformation with syrinx: a case report of an unusual presentation of Costello syndrome","authors":"Naomi S. Schwartz, Molly O. Regelmann","doi":"10.1186/s13633-019-0067-8","DOIUrl":"https://doi.org/10.1186/s13633-019-0067-8","url":null,"abstract":"","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79398056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clitoral sizes and anogenital distances in term newborns in Nigeria. 尼日利亚足月新生儿的阴蒂大小和肛门生殖器距离。
Pub Date : 2019-01-01 Epub Date: 2019-12-05 DOI: 10.1186/s13633-019-0069-6
Adesola Olubunmi Adekoya, Musili Bolanle Fetuga, Olumide Olatokunbo Jarrett, Tinuade Adetutu Ogunlesi, Jean-Pierre Chanoine, Abiola Omobonike Adekoya

Background: Previous studies suggest significant ethnic and racial differences in clitoral sizes and anogenital distances in the newborn. This study aimed to document normative data on clitoral sizes and anogenital distances of apparently normal term female infants in Sagamu.

Methods: The study was a multi-center, cross-sectional descriptive research carried out among 317 female term infants within the first 72 h of life. Interviewer-based questionnaire was applied to obtain sociodemographic data, pregnancy and birth history. A sliding digital caliper was used for measurement. Data analysis was with SPSS version 20.0.

Results: The mean clitoral length was 6.7 ± 1.6 mm while the mean clitoral width was 5.6 ± 0.8 mm. The mean fourchette-clitoris distance, anus-clitoris distance and anus-fourchette distance were 21.9 ± 2.1 mm, 35.5 ± 2.5 mm and 17.0 ± 2.6 mm respectively. The anus-clitoris and anus-fourchette distances significantly correlated with the anthropometric parameters while the clitoral measurements did not.

Conclusion: The mean values recorded in this study were higher than observed in most previous studies. This simple, affordable and non-invasive evaluation could aid early diagnosis and treatment of female infants with potentially harmful conditions such as congenital adrenal hyperplasia.

背景:先前的研究表明,新生儿的阴蒂大小和肛门生殖器距离存在显著的种族和种族差异。本研究旨在记录萨加木明显正常足月女婴的阴蒂大小和肛门生殖器距离的规范性数据 生命的h。以访谈者为基础的问卷调查用于获取社会人口学数据、妊娠和出生史。使用滑动数字卡尺进行测量。数据分析采用SPSS 20.0版本。结果:平均阴蒂长度为6.7 ± 1.6 mm,而阴蒂的平均宽度为5.6 ± 0.8 平均阴蒂距、肛门距和肛门距分别为21.9 ± 2.1 毫米,35.5 ± 2.5 mm和17.0 ± 2.6 mm。肛门-阴蒂和肛门-四脚距离与人体测量参数显著相关,而阴蒂测量则不相关。结论:本研究中记录的平均值高于以往大多数研究中观察到的平均值。这种简单、负担得起且无创的评估可以帮助患有先天性肾上腺增生等潜在有害疾病的女婴的早期诊断和治疗。
{"title":"Clitoral sizes and anogenital distances in term newborns in Nigeria.","authors":"Adesola Olubunmi Adekoya,&nbsp;Musili Bolanle Fetuga,&nbsp;Olumide Olatokunbo Jarrett,&nbsp;Tinuade Adetutu Ogunlesi,&nbsp;Jean-Pierre Chanoine,&nbsp;Abiola Omobonike Adekoya","doi":"10.1186/s13633-019-0069-6","DOIUrl":"10.1186/s13633-019-0069-6","url":null,"abstract":"<p><strong>Background: </strong>Previous studies suggest significant ethnic and racial differences in clitoral sizes and anogenital distances in the newborn. This study aimed to document normative data on clitoral sizes and anogenital distances of apparently normal term female infants in Sagamu.</p><p><strong>Methods: </strong>The study was a multi-center, cross-sectional descriptive research carried out among 317 female term infants within the first 72 h of life. Interviewer-based questionnaire was applied to obtain sociodemographic data, pregnancy and birth history. A sliding digital caliper was used for measurement. Data analysis was with SPSS version 20.0.</p><p><strong>Results: </strong>The mean clitoral length was 6.7 ± 1.6 mm while the mean clitoral width was 5.6 ± 0.8 mm. The mean fourchette-clitoris distance, anus-clitoris distance and anus-fourchette distance were 21.9 ± 2.1 mm, 35.5 ± 2.5 mm and 17.0 ± 2.6 mm respectively. The anus-clitoris and anus-fourchette distances significantly correlated with the anthropometric parameters while the clitoral measurements did not.</p><p><strong>Conclusion: </strong>The mean values recorded in this study were higher than observed in most previous studies. This simple, affordable and non-invasive evaluation could aid early diagnosis and treatment of female infants with potentially harmful conditions such as congenital adrenal hyperplasia.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-019-0069-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37449586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Disorders of sex development (DSD) web-based information: quality survey of DSD team websites. 性发育障碍(DSD)网络信息:DSD团队网站质量调查。
Pub Date : 2019-01-01 Epub Date: 2019-05-28 DOI: 10.1186/s13633-019-0065-x
Michelle M Ernst, Diane Chen, Kim Kennedy, Tess Jewell, Afiya Sajwani, Carmel Foley, David E Sandberg

Objectives: Consumers rely on online health information, particularly for unusual conditions. Disorders of Sex Development (DSD) are complex with some aspects of care controversial. Accurate web-based DSD information is essential for decision-making, but the quality has not been rigorously evaluated. The purpose of the present study was to assess the quality of online health information related to DSD presented by 12 pediatric institutions comprising the NIH-sponsored DSD-Translational Research Network (DSD-TRN).

Methods: DSD-TRN sites identified team webpages, then we identified linked webpages. We also used each institution search engine to search common DSD terms. We assessed webpages using validated tools: the Simple Measure of Gobbledygook (SMOG) determined reading level, the Patient Education Materials Assessment Tool (PEMAT) evaluated content for understandability and actionability, and the DISCERN tool assessed treatment decision-making information (for hormone replacement and surgery). We developed a "Completeness" measure which assessed the presence of information on 25 DSD topics.

Results: The SMOG reading level of webpages was at or above high-school grade level. Mean (SD) PEMAT understandability score for Team Pages and Team Links was 68% (6%); on average these pages met less than 70% of the understandability criteria. Mean (SD) PEMAT actionability score was 23% (20%); few patient actions were identified. The DISCERN tool determined that the quality of information related to hormone treatment and to surgery was poor. Sites' webpages covered 12-56% of the items on our Completeness measure.

Conclusions: Quality of DSD online content was poor, and would be improved by using a variety of strategies, such as simplifying word choice, using visual aids, highlighting actions patients can take and acknowledging areas of uncertainty. For complex conditions such as DSD, high-quality web-based information is essential to empower patients (and caregiver proxies), particularly when aspects of care are controversial.

目的:消费者依赖在线健康信息,特别是对于不寻常的情况。性发育障碍(DSD)是一种复杂的疾病,在治疗的某些方面存在争议。准确的基于网络的DSD信息对决策至关重要,但质量尚未得到严格评估。本研究的目的是评估由美国国立卫生研究院资助的DSD-转化研究网络(DSD- trn)组成的12个儿科机构提供的与DSD相关的在线健康信息的质量。方法:DSD-TRN网站识别团队网页,然后我们识别链接网页。我们还使用每个机构的搜索引擎来搜索常见的DSD术语。我们使用经过验证的工具来评估网页:简单测量的Gobbledygook(烟雾)确定阅读水平,患者教育材料评估工具(PEMAT)评估内容的可理解性和可操作性,以及辨别工具评估治疗决策信息(激素替代和手术)。我们开发了一种“完整性”度量,评估了25个DSD主题信息的存在性。结果:学生网页阅读水平达到或高于高中年级水平。Team Pages和Team Links的平均(SD) PEMAT可理解性得分为68% (6%);平均而言,这些页面只满足不到70%的可理解性标准。平均(SD) PEMAT可操作性评分为23% (20%);很少发现患者的行为。辨别工具确定与激素治疗和手术相关的信息质量很差。网站的网页覆盖了我们完整性测量中12-56%的项目。结论:DSD在线内容的质量较差,可以通过多种策略得到改善,如简化用词,使用视觉辅助工具,突出患者可以采取的行动以及承认不确定领域。对于像DSD这样的复杂疾病,高质量的基于网络的信息对于增强患者(和护理人员代理)的能力至关重要,特别是在护理方面存在争议的情况下。
{"title":"Disorders of sex development (DSD) web-based information: quality survey of DSD team websites.","authors":"Michelle M Ernst,&nbsp;Diane Chen,&nbsp;Kim Kennedy,&nbsp;Tess Jewell,&nbsp;Afiya Sajwani,&nbsp;Carmel Foley,&nbsp;David E Sandberg","doi":"10.1186/s13633-019-0065-x","DOIUrl":"https://doi.org/10.1186/s13633-019-0065-x","url":null,"abstract":"<p><strong>Objectives: </strong>Consumers rely on online health information, particularly for unusual conditions. Disorders of Sex Development (DSD) are complex with some aspects of care controversial. Accurate web-based DSD information is essential for decision-making, but the quality has not been rigorously evaluated. The purpose of the present study was to assess the quality of online health information related to DSD presented by 12 pediatric institutions comprising the NIH-sponsored DSD-Translational Research Network (DSD-TRN).</p><p><strong>Methods: </strong>DSD-TRN sites identified team webpages, then we identified linked webpages. We also used each institution search engine to search common DSD terms. We assessed webpages using validated tools: the Simple Measure of Gobbledygook (SMOG) determined reading level, the Patient Education Materials Assessment Tool (PEMAT) evaluated content for understandability and actionability, and the DISCERN tool assessed treatment decision-making information (for hormone replacement and surgery). We developed a \"Completeness\" measure which assessed the presence of information on 25 DSD topics.</p><p><strong>Results: </strong>The SMOG reading level of webpages was at or above high-school grade level. Mean (SD) PEMAT understandability score for Team Pages and Team Links was 68% (6%); on average these pages met less than 70% of the understandability criteria. Mean (SD) PEMAT actionability score was 23% (20%); few patient actions were identified. The DISCERN tool determined that the quality of information related to hormone treatment and to surgery was poor. Sites' webpages covered 12-56% of the items on our Completeness measure.</p><p><strong>Conclusions: </strong>Quality of DSD online content was poor, and would be improved by using a variety of strategies, such as simplifying word choice, using visual aids, highlighting actions patients can take and acknowledging areas of uncertainty. For complex conditions such as DSD, high-quality web-based information is essential to empower patients (and caregiver proxies), particularly when aspects of care are controversial.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-019-0065-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37288981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy. 延迟骨龄在糖皮质激素治疗的杜氏肌营养不良患者的身高和骨骼健康评价中的作用。
Pub Date : 2019-01-01 Epub Date: 2019-12-23 DOI: 10.1186/s13633-019-0070-0
E J Annexstad, J Bollerslev, J Westvik, A G Myhre, K Godang, I Holm, M Rasmussen

Background: Low bone mineral density and an increased risk of appendicular and vertebral fractures are well-established consequences of Duchenne muscular dystrophy (DMD) and the risk of fractures is exacerbated by long-term glucocorticoid treatment. Monitoring of endocrine and skeletal health and timely intervention in at-risk patients is important in the management of children with DMD.

Methods: As part of the Norwegian Duchenne muscular dystrophy cohort study, we examined the skeletal maturation of 62 boys less than 18 years old, both currently glucocorticoid treated (n = 44), previously treated (n = 6) and naïve (n = 12). The relationship between bone age, height and bone mineral density (BMD) Z-scores was explored.

Results: The participants in the glucocorticoid treated group were short in stature and puberty was delayed. Bone age was significantly delayed, and the delay increased with age and duration of treatment. The difference in height between glucocorticoid treated and naïve boys was no longer significant when height was corrected for delayed skeletal maturation. Mean BMD Z-scores fell below - 2 before 12 years of age in the glucocorticoid treated group, with scores significantly correlated with age, duration of treatment and pubertal development. When BMD Z-scores were corrected for by retarded bone age, the increase in BMD Z-scores was significant for all age groups.

Conclusion: Our results suggest that skeletal maturation should be assessed in the evaluation of short stature and bone health in GC treated boys with DMD, as failing to consider delayed bone age leads to underestimation of BMD Z-scores and potentially overestimation of fracture risk.

背景:低骨密度和增加的阑尾和椎体骨折的风险是杜氏肌营养不良症(DMD)的公认后果,长期糖皮质激素治疗会加剧骨折的风险。监测内分泌和骨骼健康并及时干预高危患者对DMD儿童的管理很重要。方法:作为挪威Duchenne肌营养不良队列研究的一部分,我们检查了62名18岁以下男孩的骨骼成熟情况,其中包括目前接受糖皮质激素治疗(n = 44),以前接受治疗(n = 6)和naïve (n = 12)。探讨骨龄、身高与骨密度(BMD) z评分之间的关系。结果:糖皮质激素治疗组受试者身材矮小,青春期延迟。骨龄明显延迟,且随年龄和治疗时间的延长而延长。使用糖皮质激素治疗的男孩和naïve男孩的身高差异在因骨骼发育延迟而进行身高矫正后不再显著。糖皮质激素治疗组12岁前平均BMD z -评分低于- 2,得分与年龄、治疗持续时间和青春期发育显著相关。当骨密度z分数被延迟骨龄校正后,所有年龄组骨密度z分数的增加都是显著的。结论:我们的研究结果表明,在评估GC治疗的DMD男孩的身高和骨骼健康时,应该评估骨骼成熟度,因为没有考虑延迟骨龄会导致BMD z -评分的低估,并可能高估骨折风险。
{"title":"The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy.","authors":"E J Annexstad,&nbsp;J Bollerslev,&nbsp;J Westvik,&nbsp;A G Myhre,&nbsp;K Godang,&nbsp;I Holm,&nbsp;M Rasmussen","doi":"10.1186/s13633-019-0070-0","DOIUrl":"https://doi.org/10.1186/s13633-019-0070-0","url":null,"abstract":"<p><strong>Background: </strong>Low bone mineral density and an increased risk of appendicular and vertebral fractures are well-established consequences of Duchenne muscular dystrophy (DMD) and the risk of fractures is exacerbated by long-term glucocorticoid treatment. Monitoring of endocrine and skeletal health and timely intervention in at-risk patients is important in the management of children with DMD.</p><p><strong>Methods: </strong>As part of the Norwegian Duchenne muscular dystrophy cohort study, we examined the skeletal maturation of 62 boys less than 18 years old, both currently glucocorticoid treated (<i>n</i> = 44), previously treated (<i>n</i> = 6) and naïve (<i>n</i> = 12). The relationship between bone age, height and bone mineral density (BMD) Z-scores was explored.</p><p><strong>Results: </strong>The participants in the glucocorticoid treated group were short in stature and puberty was delayed. Bone age was significantly delayed, and the delay increased with age and duration of treatment. The difference in height between glucocorticoid treated and naïve boys was no longer significant when height was corrected for delayed skeletal maturation. Mean BMD Z-scores fell below - 2 before 12 years of age in the glucocorticoid treated group, with scores significantly correlated with age, duration of treatment and pubertal development. When BMD Z-scores were corrected for by retarded bone age, the increase in BMD Z-scores was significant for all age groups.</p><p><strong>Conclusion: </strong>Our results suggest that skeletal maturation should be assessed in the evaluation of short stature and bone health in GC treated boys with DMD, as failing to consider delayed bone age leads to underestimation of BMD Z-scores and potentially overestimation of fracture risk.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-019-0070-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37501980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study. 特纳综合征的临床表现模式和延迟诊断:一项英国单一中心研究。
Pub Date : 2018-01-01 Epub Date: 2018-06-26 DOI: 10.1186/s13633-018-0058-1
Louise Apperley, Urmi Das, Renuka Ramakrishnan, Poonam Dharmaraj, Jo Blair, Mohammed Didi, Senthil Senniappan

Background: Early diagnosis of girls with Turner syndrome (TS) is essential to provide timely intervention and support. The screening guidelines for TS suggest karyotype evaluation in patients presenting with short stature, webbed neck, lymphoedema, coarctation of aorta or ≥ two dysmorphic features. The aim of the study was to determine the age and clinical features at the time of presentation and to identify potential delays in diagnosis of TS.

Methods: Retrospective data on age at diagnosis, reason for karyotype analysis and presenting clinical features was collected from the medical records of 67 girls with TS.

Results: The mean age of diagnosis was 5.89 (±5.3) years ranging from pre-natal to 17.9 years (median 4.6 years). 10% were diagnosed antenatally, 16% in infancy, 54% in childhood (1-12 years) and 20% in adolescence (12-18 years). Lymphoedema (27.3%) and dysmorphic features (27.3%) were the main signs that triggered screening in infancy. Short stature was the commonest presenting feature in both childhood (52.8%) and adolescent (38.5%) years. At least 12% of girls fulfilled the criteria for earlier screening but were diagnosed only at a later age (mean age = 8.78 years). 13.4% of patients had classical 45XO karyotype and 52.3% of girls had a variant karyotype.

Conclusion: Majority of girls with TS were diagnosed only after the age of 5 years. Short stature triggered evaluation for most patients diagnosed in childhood and adolescence. Lack of dedicated community height-screening programme to identify children with short stature and lack of awareness could have led to potential delays in diagnosing TS. New strategies for earlier detection of TS are needed.

背景:早期诊断女童特纳综合征(TS)是提供及时干预和支持的必要条件。TS筛查指南建议在出现身材矮小、颈蹼状、淋巴水肿、主动脉缩窄或≥两种畸形特征的患者中进行核型评估。研究的目的是确定发病时的年龄和临床特征,并确定ts诊断的潜在延迟。方法:回顾性收集67例ts女孩的病历资料,包括诊断时的年龄、核型分析的原因和表现的临床特征。结果:从产前到17.9岁(中位4.6岁),平均诊断年龄为5.89(±5.3)岁。10%在产前诊断,16%在婴儿期,54%在儿童期(1-12岁),20%在青春期(12-18岁)。淋巴水肿(27.3%)和畸形特征(27.3%)是婴儿期触发筛查的主要体征。矮小是儿童期(52.8%)和青少年期(38.5%)最常见的表现特征。至少有12%的女孩符合早期筛查的标准,但在较晚的年龄(平均年龄= 8.78岁)才被诊断出来。13.4%的患者为典型45XO核型,52.3%的女孩为变异核型。结论:大多数TS女孩在5岁后才被诊断出来。大多数在儿童期和青春期被诊断为身材矮小的患者需要进行评估。缺乏专门的社区身高筛查规划来识别身材矮小的儿童,并且缺乏认识,可能会导致诊断TS的潜在延误。
{"title":"Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study.","authors":"Louise Apperley,&nbsp;Urmi Das,&nbsp;Renuka Ramakrishnan,&nbsp;Poonam Dharmaraj,&nbsp;Jo Blair,&nbsp;Mohammed Didi,&nbsp;Senthil Senniappan","doi":"10.1186/s13633-018-0058-1","DOIUrl":"https://doi.org/10.1186/s13633-018-0058-1","url":null,"abstract":"<p><strong>Background: </strong>Early diagnosis of girls with Turner syndrome (TS) is essential to provide timely intervention and support. The screening guidelines for TS suggest karyotype evaluation in patients presenting with short stature, webbed neck, lymphoedema, coarctation of aorta or ≥ two dysmorphic features. The aim of the study was to determine the age and clinical features at the time of presentation and to identify potential delays in diagnosis of TS.</p><p><strong>Methods: </strong>Retrospective data on age at diagnosis, reason for karyotype analysis and presenting clinical features was collected from the medical records of 67 girls with TS.</p><p><strong>Results: </strong>The mean age of diagnosis was 5.89 (±5.3) years ranging from pre-natal to 17.9 years (median 4.6 years). 10% were diagnosed antenatally, 16% in infancy, 54% in childhood (1-12 years) and 20% in adolescence (12-18 years). Lymphoedema (27.3%) and dysmorphic features (27.3%) were the main signs that triggered screening in infancy. Short stature was the commonest presenting feature in both childhood (52.8%) and adolescent (38.5%) years. At least 12% of girls fulfilled the criteria for earlier screening but were diagnosed only at a later age (mean age = 8.78 years). 13.4% of patients had classical 45XO karyotype and 52.3% of girls had a variant karyotype.</p><p><strong>Conclusion: </strong>Majority of girls with TS were diagnosed only after the age of 5 years. Short stature triggered evaluation for most patients diagnosed in childhood and adolescence. Lack of dedicated community height-screening programme to identify children with short stature and lack of awareness could have led to potential delays in diagnosing TS. New strategies for earlier detection of TS are needed.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-018-0058-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36294041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Challenging diagnosis of congenital hyperinsulinism in two infants of diabetic mothers with rare pathogenic KCNJ11 and HNF4A gene variants. 两名患有罕见致病性KCNJ11和HNF4A基因变异的糖尿病母亲的婴儿先天性高胰岛素血症的诊断具有挑战性
Pub Date : 2018-01-01 Epub Date: 2018-07-17 DOI: 10.1186/s13633-018-0060-7
Lina Huerta-Saenz, Carol Saunders, Yun Yan

Background: Congenital hyperinsulinism (CHI) is the leading cause of persistent hypoglycemia in infants. The infants of diabetic mothers (IDMs) very frequently present with neonatal hypoglycemia associated to transient hyperinsulinism however the incidence of CHI in IDMs is unknown.

Case presentation: Here we report 2 cases of CHI where the diagnoses were challenged and delayed because both patients were infants of diabetic mothers (IDMs) and had concomitant complicated medical conditions. Case 1 was heterozygous for a likely pathogenic variant in KCNJ11(p.Arg206Cys), and Case 2 was heterozygous for a pathogenic HNF4A variant, (p.Arg267Cys). HNF4A-associated CHI is very rare, and this particular case had a clinical phenotype quite different from that of previously described HNF4A-CHI cases.

Conclusions: This case series is one of few reports in the medical literature describing two IDMs with persistent recurrent hypoglycemia secondary to CHI, and a different clinical phenotype for HNF4A-associated CHI. IDMs typically present with transient hyperinsulinism lasting no more than 2-3 days. Since being an IDM does not exclude CHI, this diagnosis should always be considered as the mostly likely etiology if neonatal hypoglycemia persists longer than the described time frame and genetic testing for CHI confirmation is highly suggested.

背景:先天性高胰岛素血症(CHI)是导致婴儿持续低血糖的主要原因。糖尿病母亲(IDMs)的婴儿经常出现与短暂性高胰岛素血症相关的新生儿低血糖,但IDMs中CHI的发生率尚不清楚。病例介绍:这里我们报告2例CHI的诊断受到质疑和延迟,因为两例患者都是糖尿病母亲(IDMs)的婴儿,并伴有复杂的医疗条件。病例1为KCNJ11的一种可能致病变异(p.Arg206Cys)的杂合,病例2为一种致病性HNF4A变异(p.Arg267Cys)的杂合。与hnf4a相关的CHI非常罕见,该特殊病例的临床表型与先前描述的HNF4A-CHI病例完全不同。结论:该病例系列是医学文献中为数不多的报道之一,描述了两例idm伴继发于CHI的持续复发性低血糖,以及hnf4a相关CHI的不同临床表型。idm通常表现为短暂性高胰岛素血症,持续时间不超过2-3天。由于IDM并不排除CHI,如果新生儿低血糖持续时间超过所描述的时间框架,则应始终将此诊断视为最可能的病因,强烈建议进行基因检测以确认CHI。
{"title":"Challenging diagnosis of congenital hyperinsulinism in two infants of diabetic mothers with rare pathogenic <i>KCNJ11</i> and <i>HNF4A</i> gene variants.","authors":"Lina Huerta-Saenz,&nbsp;Carol Saunders,&nbsp;Yun Yan","doi":"10.1186/s13633-018-0060-7","DOIUrl":"https://doi.org/10.1186/s13633-018-0060-7","url":null,"abstract":"<p><strong>Background: </strong>Congenital hyperinsulinism (CHI) is the leading cause of persistent hypoglycemia in infants. The infants of diabetic mothers (IDMs) very frequently present with neonatal hypoglycemia associated to transient hyperinsulinism however the incidence of CHI in IDMs is unknown.</p><p><strong>Case presentation: </strong>Here we report 2 cases of CHI where the diagnoses were challenged and delayed because both patients were infants of diabetic mothers (IDMs) and had concomitant complicated medical conditions. Case 1 was heterozygous for a likely pathogenic variant in <i>KCNJ11</i>(p.Arg206Cys), and Case 2 was heterozygous for a pathogenic <i>HNF4A</i> variant, (p.Arg267Cys). <i>HNF4A</i>-associated CHI is very rare, and this particular case had a clinical phenotype quite different from that of previously described <i>HNF4A</i>-CHI cases.</p><p><strong>Conclusions: </strong>This case series is one of few reports in the medical literature describing two IDMs with persistent recurrent hypoglycemia secondary to CHI, and a different clinical phenotype for <i>HNF4A</i>-associated CHI. IDMs typically present with transient hyperinsulinism lasting no more than 2-3 days. Since being an IDM does not exclude CHI, this diagnosis should always be considered as the mostly likely etiology if neonatal hypoglycemia persists longer than the described time frame and genetic testing for CHI confirmation is highly suggested.</p>","PeriodicalId":14271,"journal":{"name":"International Journal of Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13633-018-0060-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36327331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
International Journal of Pediatric Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1